Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04983940 · ClinicalTrials.gov registry record · Phase 4
Patient Satisfaction After Switching to Oral Testosterone Undecanoate
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT04983940 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 41 participants.
The verdict
NCT04983940, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy.
Interventions
- DRUG Jatenzo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-06-18 |
| Est. Completion | 2023-04-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04983940
The ClinicalTrials.gov registry entry for NCT04983940 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Jatenzo is the first listed.
NCT04983940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04983940 about?
NCT04983940 is a clinical study titled "Patient Satisfaction After Switching to Oral Testosterone Undecanoate". The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy.
What is the current status of trial NCT04983940?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2021-06-18. Estimated completion is 2023-04-06.
What interventions are being tested in trial NCT04983940?
The interventions under investigation include: Jatenzo (DRUG).
Who is sponsoring clinical trial NCT04983940?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.